Hainan Haiyao Co., Ltd. (000566)

Hainan Haiyao Co., Ltd. (000566)

Haikou pharmaceutical factory, the predecessor of the company, was founded in 1965 and listed on Shenzhen Stock Exchange in 1994 (Stock Code: 000566). It is a leading enterprise in Hainan pharmaceutical industry. On March 24, 2020, Xinxing Jihua pharmaceutical and Hainan Haiyao completed the strategic restructuring, and new Haiyao became a mixed ownership enterprise controlled by the central enterprise, opening a new journey of Haiyao development.

Guided by scientific and technological innovation, the company has a complete independent R & D platform, and R & D institutions in Beijing, Shanghai, Hainan, Hong Kong, China and the United States. The innovation system is complete, and the R & D pipeline has international competitiveness.

The main products of the company cover intermediates, APIs, chemical innovative drugs, modern Chinese medicine, biological drugs, cellular immunity, high-end medical devices and other fields. The company has established intermediates and APIs bases in Chongqing and Jiangsu, and preparation production bases in Tianjin and Hainan. It has the advantages of the whole industry chain of characteristic antibiotics, focusing on high value-added generic drugs and characteristic drugs, The core varieties are well-known in the industry.

Looking forward to the future, Hainan Haiyao will continue to uphold the mission of "rejuvenating the country and protecting the army for the people", practice the healthy China strategy and innovation driven strategy, rely on the advantages of "emergency" and "medicine", adhere to the "innovation and emergency" dual wheel drive strategy, on the one hand, march into high-end biopharmaceuticals, promote high-quality development, on the other hand, focus on emergency medicine, adhere to the differentiated positioning, With anti infective drugs as the breakthrough point, adhere to the strategic direction of "one main and multiple", gradually build a high-level "prevention, diagnosis, treatment and preparation" R & D chain and industrial chain to deal with new public health emergencies, and strive to become a reliable and reliable strategic guarantee force to protect people's health and make greater contribution to human health.

>> electrical submersible pump manufacturers esp pump cable manufacturer